FDA approves a device to prevent migraines
If migraines have ever interrupted your concentration when studying or motivation when partying, there’s a device for that.
The Food and Drug Administration recently approved a device that will prevent migraines. It is, a CNN article reports, the first of its kind.
A drug-free method of treating migraines, the device named Cefaly rests on a person’s head like a tiara and works by neurostimulation.
Cefaly delivers electric currents through a battery-powered electrode that is positioned on the center of the forehead. The treatment is designed to alter the trigger threshold of migraine headaches.
As the pain threshold is altered, migraines become less frequent and less painful.
Sixty-seven people were subjected to Cefaly in a controlled trial published in the Official Journal of the American Academy of Neurology last month, the CNN article reports. The treatment reduced migraine episodes by 50 percent in 38 percent of the subjects. On average, it also reduced chronic migraine attacks by two per month.
The study did not find that Cefaly made the migraines less severe.
“New therapies are needed in migraine (research), and further studies of neurostimulation using innovative study designs are warranted to explore the optimum way to create an acceptable evidence base for widespread use of this potentially valuable treatment,” Dr. Eishi Asano, associate professor of pediatrics and neurology at Wayne State University in Detroit, wrote in a journal editorial.
Currently the device is available for sale in Canada.